Entacapone Combination With Imatinib for Treatment of GIST
Status:
Unknown status
Trial end date:
2020-07-01
Target enrollment:
Participant gender:
Summary
This study evaluates the combination of entacapone and imatinib in the treatment of
gastrointestinal stromal Tumors who have progressed on the setting of at least Imatinib and
Sunitinib. 5 participants will be included in this open-label observatory study.